Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.

Boylan KL, Misemer B, De Rycke MS, Andersen JD, Harrington KM, Kalloger SE, Gilks CB, Pambuccian SE, Skubitz AP.

Int J Mol Sci. 2011 Feb 22;12(2):1334-58. doi: 10.3390/ijms12021334.

2.

Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.

Matte I, Legault CM, Garde-Granger P, Laplante C, Bessette P, Rancourt C, Piché A.

Clin Exp Metastasis. 2016 Dec;33(8):839-852. Epub 2016 Sep 9.

PMID:
27612856
3.

Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.

Sodek KL, Ringuette MJ, Brown TJ.

Int J Cancer. 2009 May 1;124(9):2060-70. doi: 10.1002/ijc.24188.

4.

Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.

Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE, Skubitz AP.

Am J Pathol. 2001 Dec;159(6):2071-80.

5.

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.

Cocco E, Casagrande F, Bellone S, Richter CE, Bellone M, Todeschini P, Holmberg JC, Fu HH, Montagna MK, Mor G, Schwartz PE, Arin-Silasi D, Azoudi M, Rutherford TJ, Abu-Khalaf M, Pecorelli S, Santin AD.

BMC Cancer. 2010 Jul 2;10:349. doi: 10.1186/1471-2407-10-349.

6.

An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.

Pettee KM, Dvorak KM, Nestor-Kalinoski AL, Eisenmann KM.

PLoS One. 2014 Feb 28;9(2):e90371. doi: 10.1371/journal.pone.0090371. eCollection 2014.

7.

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M.

BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359.

8.

Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.

Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP.

Gynecol Oncol. 2004 Apr;93(1):170-81.

PMID:
15047232
9.

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ.

Clin Cancer Res. 2003 Jul;9(7):2567-75.

10.

TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.

Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Endocr Relat Cancer. 2016 Mar;23(3):147-59. doi: 10.1530/ERC-15-0383. Epub 2015 Dec 8.

11.

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.

Hicks DA, Galimanis CE, Webb PG, Spillman MA, Behbakht K, Neville MC, Baumgartner HK.

BMC Cancer. 2016 Oct 11;16(1):788.

12.

BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.

Peart TM, Correa RJ, Valdes YR, Dimattia GE, Shepherd TG.

Clin Exp Metastasis. 2012 Apr;29(4):293-313. doi: 10.1007/s10585-011-9451-3. Epub 2012 Jan 17.

PMID:
22249415
13.

Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease.

Chen JL, David J, Cook-Spaeth D, Casey S, Cohen D, Selvendiran K, Bekaii-Saab T, Hays JL.

Mol Cancer Res. 2017 Jan;15(1):26-34. doi: 10.1158/1541-7786.MCR-16-0200-T. Epub 2016 Nov 2.

PMID:
27807188
14.

VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5.

Herr D, Sallmann A, Bekes I, Konrad R, Holzheu I, Kreienberg R, Wulff C.

Gynecol Oncol. 2012 Oct;127(1):210-6. doi: 10.1016/j.ygyno.2012.05.002. Epub 2012 May 8.

PMID:
22579791
15.

Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.

Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, Zhu H, Thompson EW, Quinn MA, Findlay JK, Ahmed N.

PLoS One. 2012;7(10):e46858. doi: 10.1371/journal.pone.0046858. Epub 2012 Oct 8.

16.
17.

Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.

Carduner L, Picot CR, Leroy-Dudal J, Blay L, Kellouche S, Carreiras F.

Exp Cell Res. 2014 Jan 15;320(2):329-42. doi: 10.1016/j.yexcr.2013.11.011. Epub 2013 Nov 27.

PMID:
24291221
18.

Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Dahiya N, Becker KG, Wood WH 3rd, Zhang Y, Morin PJ.

PLoS One. 2011;6(7):e22119. doi: 10.1371/journal.pone.0022119. Epub 2011 Jul 15.

19.

Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Burleson KM, Hansen LK, Skubitz AP.

Clin Exp Metastasis. 2004;21(8):685-97.

PMID:
16035613
20.

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin PN, Chevrette M, Provencher DM, Mes-Masson AM.

Neoplasia. 2007 Oct;9(10):820-9.

Supplemental Content

Support Center